South America
When it comes to a novel virus like SARS-CoV2, a certain amount of “rolling with the punches” is required, and governments and global organizations like the World Health Organization are beginning to dismiss certain treatments and devote themselves wholeheartedly to others.
BioSpace provides an up-to-date overview of these deals and the projected COVID-19 vaccine doses each company plans to have within the next couple of years.
Even when a first vaccine is finally approved, much of the developing world currently stands to be left behind, as it was during the 2009 H1N1 pandemic.
More than 150 countries have signed on to a World Health Organization program to ensure global access to a COVID-19 vaccine, however, the United States, Russia and China refrained from signing the agreement.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 20, 2020.
It was discovered in Lake Pampulha, an artificial lake in Belo Horizonte, a city in Brazil, and infects amoeba.
Eolo Pharma, a pioneering South American biotech company developing multiple drugs that stop low grade chronic inflammation, is pleased to announce that it has successfully closed an oversubscribed Series A financing round of 2.7 million dollars.
Two of Regenstrief Institute’s leaders are sharing their expertise in artificial intelligence and data infrastructure at a workshop hosted by Brazil’s National Institute of Science and Technology in Scientific Assisted Medicine in Sao Paulo, Brazil.
Auris Medical Holding Ltd. provided a business update, including a review of recent clinical, regulatory and operational highlights and progress.
PRESS RELEASES